Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (Q233284): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed label, description and/or aliases in nl: translated_label)
(‎Created claim: summary (P836): Co-targeting PIM kinase in geneesmiddel resistente niet-kleine cel longkanker, translated_summary)
Property / summary
 
Co-targeting PIM kinase in geneesmiddel resistente niet-kleine cel longkanker (Dutch)
Property / summary: Co-targeting PIM kinase in geneesmiddel resistente niet-kleine cel longkanker (Dutch) / rank
 
Normal rank
Property / summary: Co-targeting PIM kinase in geneesmiddel resistente niet-kleine cel longkanker (Dutch) / qualifier
 
point in time: 27 November 2021
Timestamp+2021-11-27T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0

Revision as of 11:02, 27 November 2021

Project Q233284 in Ireland
Language Label Description Also known as
English
Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer
Project Q233284 in Ireland

    Statements

    0 references
    16,929.64 Euro
    0 references
    33,859.27 Euro
    0 references
    50.0 percent
    0 references
    1 January 2016
    0 references
    1 January 2018
    0 references
    Trinity College Dublin
    0 references
    Co-targeting PIM kinase in drug resistant Non-Small Cell Lung Cancer (English)
    0 references
    Co-cibler la PIM kinase dans le cancer du poumon non à petites cellules résistant aux médicaments (French)
    25 November 2021
    0 references
    Co-targeting PIM-Kinase in medikamentösen Non-Small Cell Lung Cancer (German)
    25 November 2021
    0 references
    Co-targeting PIM kinase in geneesmiddel resistente niet-kleine cel longkanker (Dutch)
    27 November 2021
    0 references

    Identifiers

    215
    0 references